Replies to post #7310 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

I appreciate your final point about the limitations Horizon may have had in terms of resources, and how Amgen might be able to fund the necessary trials. That may prove to be the key, but, as you say, only time will tell.